Chemotherapy Press Release

Title Picture
11/06/2018 - 05:16
Combined Approach Offers Hope to Lung Cancer Patients Who Become Resistant to Drugs
WeizmannInstitute's picture
WeizmannInstitute
11/05/2018 - 21:56
St. Baldricks Foundation and Osteosarcoma Collaborative Partner to Fund Lifesaving Childhood Cancer Research
St. Baldrick's Foundation's picture
St. Baldrick's ...
11/05/2018 - 16:03
MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan
MEI Pharma's picture
MEI Pharma
11/04/2018 - 19:20
Fluorescent marker can help guide surgeons to remove dangerous brain tumour cells more accurately
University of Bristol's picture
University of B...
11/04/2018 - 19:19
Epic Sciences Joins Forces with Canadian Consortium of Investigators to Predict Late Recurrence of Metastatic Breast Cancer
Epic Sciences's picture
Epic Sciences
11/02/2018 - 11:38
Coverage of Hormonal Breast Cancer Therapies Increased in States that Expanded Medicaid
American Association for Cancer Research's picture
American Associ...
11/01/2018 - 21:57
Novartis data at ASH and SABCS show strength of pipeline and portfolio in hematology and oncology
Novartis's picture
Novartis
11/01/2018 - 15:44
MEI Pharma to Present Clinical Data from Three Oncology Programs at the 2018 American Society of Hematology (ASH) Annual Meeting
MEI Pharma's picture
MEI Pharma
11/01/2018 - 15:17
National Cancer Institute awards Carlo Maley $10.8M grant
Biodesign Institute's picture
Biodesign Institute
11/01/2018 - 08:10
New OFID Case Report Highlights Importance of Herd Immunity
Infectious Diseases Society of America's picture
Infectious Dise...
11/01/2018 - 02:52
Phase III data showed that Venclexta/Venclyxto plus Gazyva/Gazyvaro reduced the risk of disease worsening or death in people with previously untreated chronic lymphocytic leukaemia with co-morbidities
Rocheusa's picture
Rocheusa
11/01/2018 - 02:02
Roche announces EU approval of Venclyxto plus MabThera for people with previously treated chronic lymphocytic leukaemia
Rocheusa's picture
Rocheusa
11/01/2018 - 00:34
Low-fat diet increases cancer survival rate in mice, study finds
UCLA's picture
UCLA
10/31/2018 - 14:26
Phase III Data Showed That Venclexta Plus Gazyva Reduced The Risk Of Disease Worsening Or Death In People With Previously Untreated Chronic Lymphocytic Leukemia With Co-Morbidities
Genentech's picture
Genentech
10/30/2018 - 03:35
Halozyme Licenses New ENHANZE Targets For $25 Million Upfront Payment, Future Milestones And Royalties
Halozyme's picture
Halozyme
10/29/2018 - 17:53
Two-cells-in-one combo could be platform to bolster leukemia treatment
UCLA's picture
UCLA
10/29/2018 - 15:26
Important News About Your Health Coverage
Roswell Park Cancer Institute's picture
Roswell Park Ca...
10/29/2018 - 13:52
Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX AR-V7 Nucleus Detect Test in Patients with Metastatic Castrate Resistant Prostate Cancer, Effective
Epic Sciences's picture
Epic Sciences
10/26/2018 - 09:16
Turning cells against pancreatic cancer
CSHL's picture
CSHL
10/25/2018 - 05:17
Halozyme Announces First Clinical Dosing In Bristol-Myers Squibb's Phase 1 Trial Of BMS-986179 With Enhanze Technology
Halozyme's picture
Halozyme
10/25/2018 - 04:24
FNIH Biomarkers Consortium and Critical Path Institute Achieve the First Ever Qualification of a Clinical Safety Biomarker by the U.S. Food and Drug Administration
FNIH's picture
FNIH
10/24/2018 - 15:06
Leading women of biotech share insights
Biodesign Institute's picture
Biodesign Institute
10/24/2018 - 14:40
Targeted drug could slow progression of ovarian cancer in women with faulty BRCA gene
Cancer Research UK's picture
Cancer Research UK
10/24/2018 - 09:14
OHSU, PSU Collaborate to advance human health and safety innovations
Portland State University's picture
Portland State ...
10/23/2018 - 22:02
Christiana Care Health System Wins 2018 ANCC Magnet Prize
American Nurses Association's picture
American Nurses...
10/23/2018 - 18:13
CEL-SCI RECEIVES ABOUT $8 MILLION FROM WARRANT EXERCISES
Cel-Sci's picture
Cel-Sci
10/23/2018 - 10:36
Targeted drug could extend lives of some women with advanced breast cancer
Cancer Research UK's picture
Cancer Research UK
10/23/2018 - 10:34
Immunotherapy trial shows promise for some women with an aggressive breast cancer
Cancer Research UK's picture
Cancer Research UK
10/22/2018 - 15:42
First Results of New Data of ABRAXANE in Combination with Atezolizumab Presented at ESMO 2018
Celgene's picture
Celgene
10/22/2018 - 11:31
Patients with HPV-positive throat cancer should receive chemotherapy not cetuximab
University of Birmingham's picture
University of B...
10/22/2018 - 09:43
Exercise buddies unite against cancer
QueenslandUniv's picture
QueenslandUniv
10/22/2018 - 08:34
Genentechs Tecentriq Plus Chemotherapy (Carboplatin and Abraxane) as an Initial Treatment Helped People With Advanced Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy Alone
Genentech's picture
Genentech
10/22/2018 - 07:58
Genomic Health Announces Multiple Studies Reinforcing Value of Oncotype DX Tests in Guiding Treatment for Breast and Prostate Cancer Patients
Genomic's picture
Genomic
10/22/2018 - 01:23
Halozyme Provides Summary Results Of Data For PEGPH20 Combination Treatments Presented At ESMO 2018 Congress
Halozyme's picture
Halozyme
10/21/2018 - 20:42
International Community Must Establish Mechanisms to Sell Humanitarian Goods to Iran, Iranian Government Must Ensure Affordability
ICHRI's picture
ICHRI
10/21/2018 - 20:41
Roches Tecentriq plus chemotherapy (carboplatin and Abraxane) as an initial treatment helped people with advanced non-squamous non-small cell lung cancer live significantly longer compared to chemotherapy alone
Rocheusa's picture
Rocheusa
10/21/2018 - 19:16
Paul Azinger Joins NBC Sports Group, Succeeding Johnny Miller as Lead Golf Analyst
Golf Channel's picture
Golf Channel
10/21/2018 - 16:42
SOLO-1 Phase III trial demonstrates Lynparza maintenance therapy cut risk of disease progression or death by 70% in patients with newly-diagnosed, advanced BRCA-mutated ovarian cancer
AstraZeneca's picture
AstraZeneca
10/20/2018 - 19:38
Cancer trial shows treating the prostate with radiotherapy improves survival
University of Birmingham's picture
University of B...
10/20/2018 - 09:44
Komen Hails Findings from IMpassion130 Trial Showing New Treatment Option for Metastatic Triple Negative Breast Cancers
Susan G Komen's picture
Susan G Komen
10/19/2018 - 23:31
Pfizer Presents Overall Survival Data From PALOMA-3 Trial of IBRANCE (palbociclib) in Patients With HR+, HER2- Metastatic Breast Cancer
Pfizer's picture
Pfizer
10/19/2018 - 22:42
Roches Tecentriq in combination with Abraxane improves outcomes as an initial treatment for people with PD-L1-positive metastatic triple-negative breast cancer
Rocheusa's picture
Rocheusa
10/19/2018 - 20:22
Genentechs Tecentriq in Combination With Abraxane Improves Outcomes as an Initial Treatment for People With PD-L1-Positive Metastatic Triple-Negative Breast Cancer
Genentech's picture
Genentech
10/19/2018 - 19:48
BioLineRx Discloses Additional Data from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress
Biolinerx's picture
Biolinerx
10/19/2018 - 18:03
New data on mechanisms of acquired resistance after 1st-line Tagrisso in NSCLC support initiation of ORCHARD trial to explore post-progression treatment options
AstraZeneca's picture
AstraZeneca
10/19/2018 - 10:02
Real-world study shows using Giotrif
Boehringer-Ingelheim's picture
Boehringer-Ingelheim
10/19/2018 - 08:43
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri, Biosimilar Trastuzumab
Mylan's picture
Mylan
10/19/2018 - 08:24
BioLineRx Presents Top-Line Results from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress
Biolinerx's picture
Biolinerx
10/18/2018 - 16:53
Guidelines on Relation with Medical Institutions and Patient Groups
Chugai's picture
Chugai
10/18/2018 - 16:28
Daiichi Sankyo Initiates Phase 1 Study of AXL Inhibitor DS-1205 in Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer
Daiichi Sankyo's picture
Daiichi Sankyo
10/18/2018 - 14:25
Stem Cell Agency Invests in New Immunotherapy Approach to HIV, Plus Promising Projects Targeting Blindness and Leukemia
CIRM's picture
CIRM
10/18/2018 - 08:23
Chelsea legend Gianfranco Zola surprises Blues fan and cancer survivor
Cancer Research UK's picture
Cancer Research UK
10/17/2018 - 18:57
Cambridge leads a 10 million interdisciplinary collaboration to target the most challenging of cancers.
University of Cambridge's picture
University of C...
10/17/2018 - 17:44
Translating research into impact
MIT's picture
MIT
10/17/2018 - 17:19
Exercise shown to reduce numbers of circulating tumor cells in patients with colon cancer
Dana Farber's picture
Dana Farber
10/17/2018 - 16:48
Micaelas Army Foundation and the St. Baldricks Foundation Partner to Fund Childhood Cancer Research
St. Baldrick's Foundation's picture
St. Baldrick's ...
10/17/2018 - 05:38
Daiichi Sankyo Submits Application in Japan for FLT3 Inhibitor Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Daiichi Sankyo's picture
Daiichi Sankyo
10/17/2018 - 04:43
Roche reports very strong growth in the first nine months of 2018
Rocheusa's picture
Rocheusa
10/16/2018 - 20:20
Unexpected role of enzyme may help develop anti-cancer drugs
UniversityCollegeLondon's picture
UniversityColle...
10/16/2018 - 16:51
Why Some Drugs Make Other Drugs Last Longer (Or Shorter)
American Council on Science and Health's picture
American Counci...